TrialCancer immunology, immunotherapy : CII2017

Elevated basal antibody-dependent cell-mediated cytotoxicity (ADCC) and high epidermal growth factor receptor (EGFR) expression predict favourable outcome in patients with locally advanced head and neck cancer treated with cetuximab and radiotherapy.

Laura Lattanzio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.